Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Makris

Showing results (41-50 of 320) with videos related to

Pageof 32
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 6, 2015
Choosing and using non-steroidal anti-inflammatory drugs in haemophiliaD R J Arachchillage, M Makris
Eye (London, England)|August 18, 1999
Retinal vein occlusion, the contraceptive pill and the prothrombin 20210A alleleM Edwards, S Longstaff, M Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 18, 2018
Haemophilia of the third ageC Harrison, G Saccullo, M Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Biovigilance and pharmacovigilance for haemophiliaM Weinstein, M Makris, C A Ludlam
Thrombosis and Haemostasis|March 1, 1996
Warfarin induced skin necrosis associated with activated protein C resistanceM Makris, G Bardhan, F E Preston
International Journal of Immunopathology and Pharmacology|March 14, 2008
Allergic inflammation and adipocytokinesT C Theoharides, M Makris, D Kalogeromitros
Transfusion Medicine (Oxford, England)|April 29, 2004
Unconventional diagnosis of Normandy-type von Willebrand's disease in a blood donorS Kashyap, I M Nesbitt, M Makris
British Journal of Haematology|June 1, 1994
Increased soluble IL-2 receptor levels in HCV-infected haemophiliacs: a possible indicator of liver disease severityM Makris, F E Preston, S Ralph
Anaesthesia|November 14, 2013
A replyM Makris, W Harrop-Griffiths, T Cook
British Journal of Haematology|June 3, 1999
The common haemochromatosis mutation does not increase the risk of thrombosis in patients with factor V LeidenS Banypersad, M E Daly, M Makris
Pageof 32

Showing results (41-50 of 320) with videos related to

Sort By:
Pageof 32
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 6, 2015
Choosing and using non-steroidal anti-inflammatory drugs in haemophiliaD R J Arachchillage, M Makris
Eye (London, England)|August 18, 1999
Retinal vein occlusion, the contraceptive pill and the prothrombin 20210A alleleM Edwards, S Longstaff, M Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 18, 2018
Haemophilia of the third ageC Harrison, G Saccullo, M Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Biovigilance and pharmacovigilance for haemophiliaM Weinstein, M Makris, C A Ludlam
Thrombosis and Haemostasis|March 1, 1996
Warfarin induced skin necrosis associated with activated protein C resistanceM Makris, G Bardhan, F E Preston
International Journal of Immunopathology and Pharmacology|March 14, 2008
Allergic inflammation and adipocytokinesT C Theoharides, M Makris, D Kalogeromitros
Transfusion Medicine (Oxford, England)|April 29, 2004
Unconventional diagnosis of Normandy-type von Willebrand's disease in a blood donorS Kashyap, I M Nesbitt, M Makris
British Journal of Haematology|June 1, 1994
Increased soluble IL-2 receptor levels in HCV-infected haemophiliacs: a possible indicator of liver disease severityM Makris, F E Preston, S Ralph
Anaesthesia|November 14, 2013
A replyM Makris, W Harrop-Griffiths, T Cook
British Journal of Haematology|June 3, 1999
The common haemochromatosis mutation does not increase the risk of thrombosis in patients with factor V LeidenS Banypersad, M E Daly, M Makris
Pageof 32